利用植物生产重组药用蛋白的研究现状

在线阅读下载PDF

导出

摘要本文概述了利用植物生产重组蛋白,特别是诊断、治疗和预防用重组蛋白的历史和技术基础。简要分析了该类技术的局限性及其解决办法。

作者莫蓓莘尤力群

机构地区香港中文大学生物学系 <华东师范大学学报>编辑部

出处《生物学教学》北大核心 2005年第8期9-11,共3页 Biology Teaching

关键词药用蛋白植物转基因技术局限性安全性表达系统

参考文献19

1Schwartz JR. 2001. Advances in Escherichia cili production of therapeutic proteins. Current Opinion in Biotechnology, 12 (2) : 195 - 201.
2Chu L, Robinson DK. 2001. Industrial choices for protein production by large scale cell culture. Current Opinion in B iotechnology, 12 (2) :180-187.
3Houdebaine LM. 2000. Transgenic animal bioreactors. Transgenic Research,9(5) :305-320.
4Barta A. 1986. The expression of a nopaline synthase human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Molecular Biology,6(2) :347-357.
5Hiatt A, Cafferkey R, Bowdish K. 1989. Production of antibodies intransgenic plants. Nature,342 (6245) :76-78.
6Kathuria S. 2002. Effcacy of plant - produced recombinant antibodies against HGG. Human Reproduction, 17 (8) :2054 - 2061.
7Mason HS, Lam DMK, Arntzen CJ, 1992, Expression of hepatitis B surface antigen in transgenic plants, PNAS ,89( 15 ) :11745 -11749.
8Thanavala Y, Yang YF, Lyos P, et al. 1995. lmmunogenicity of traslsgenic plant -derived hepatitis B surface antigen. PNAS,92 (8) :3358 - 3361.
9Kapusta J. 1999. A plant- derived edible vaccine against hepatitis B virus. Journal of The Federation of American Societies for Experimental Biology, 13 ( 13 ) : 1796 - 1799.
10Stoger E. 2000. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Molecular Biology ,42 (4) : 583 - 590.

生物学教学

2005年第8期

内容加载中请稍等...